Financing resistance | Why new investors are urgently needed and where they come from


Financing resistance | Why new investors are urgently needed and where they come from

Moderator: Peter Beyer – Senior Advisor Department of Essential Medicines & Health Products, WHO

Speakers:

  • Thomas Cueni – Director General, IFPMA 
    This content has been restricted to logged in users only. Please login to view this content.
  • James Anderson – Head of Corporate Government Affairs, GSK
  • Silas Holland – Head of External Affairs for the AMR Action Fund &  Director for Global Public Policy MSD
    This content has been restricted to logged in users only. Please login to view this content.
  • Deborah A O’Neil – CEO, NovaBiotics Ltd & Board Member, BEAM Alliance
    This content has been restricted to logged in users only. Please login to view this content.
  • Aleks Engel – Partner, Novo Holdings (Novo Seeds) & Director, REPAIR Impact Fund at Novo Holdings 
    This content has been restricted to logged in users only. Please login to view this content.
Play Video


This might also be of interest for you: